About Usan Pharmaceuticals Private Limited
Data last updated:
Usan Pharmaceuticals Private Limited is a private limited company based in Mumbai, Maharashtra, India. It operates in the pharmaceutical retail and distribution segment of the pharmaceuticals sector. It was incorporated on 13 August 1974 and has been in existence for over 52 years.
The company is registered with the Registrar of Companies (ROC), Mumbai, under CIN U24239MH1974PTC017730. Its GSTIN is 27AAACU0091N1Z4 (Maharashtra).
The company has an authorised share capital of ₹5 Lakh and a paid-up capital of ₹1 Lakh. It is led by directors Vimal Jaswa (Managing Director) and Julie Vimal Jaswa.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at 39 – B Syren Road Andhri (East), Mumbai, Maharashtra, India – 400093.
As per the financials filed for FY 2025, the company reported a revenue of ₹29.79 Cr, a decline of 7% compared to the previous year. For the same year it recorded a net loss of ₹76.03 Lakh (net margin -2.6%) and EBITDA of -₹55.67 Lakh (EBITDA margin -1.9%). Revenue has grown at a compounded annual rate (CAGR) of 35% over three years and 50% over five years.
As per MCA filings, the company has open charges of ₹4.8 Lakh on record. Court records list 7 cases involving the company, including 1 filed by the company and 6 filed against it; 2 cases are pending.
The current compliance status is marked as compliant by the Registrar of Companies. For more details, the company can be reached via its website usanpharma.com.
Company details
Contact details
Usan Pharmaceuticals Private Limited's registered office is in Mumbai, Maharashtra. Its website is usanpharma.com. Its e-mail address and telephone number are in the company report.
- Email
- Telephone
- Website
- Registered Address39 – B Syren Road Andhri (East), Mumbai, Maharashtra, India – 400093
- IndustryPharma, Pharmaceutical Retailers & Distributors
To see the full contact details of Usan Pharmaceuticals Private Limited, buy the company report.
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Business activity
The main business activity of Usan Pharmaceuticals is trade. In detail, this covers wholesale trading.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| G | Trade | G1 | Wholesale Trading |
To see the full business activity and turnover split of Usan Pharmaceuticals Private Limited, buy the company report.
Financials of Usan Pharmaceuticals Private Limited
FY 2025 filings availableUsan Pharmaceuticals Private Limited reported revenue of ₹29.79 Cr (down 7% YoY) for FY 2025.
Compounded Annual Growth Rate (CAGR)
Revenue fell 7% in the latest year, but over five years it has grown at a compounded annual rate (CAGR) of 50%. EBITDA rose 71% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | -₹55.67 Lakh | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | -₹76.03 Lakh | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | -1.9% | ||||
| Net Profit Margin | -2.6% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Usan Pharmaceuticals Private Limited, buy the company report.
Board of directors of Usan Pharmaceuticals Private Limited
Usan Pharmaceuticals has 2 current directors and 4 former directors. Current directors are listed first, with their designation and appointment date.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Julie Vimal Jaswa | Director | 15 Mar 2019 | 7 Years 7 Months | Current |
| Vimal Jaswa | Managing Director | 26 Apr 2001 | 25 Years 6 Months | Current |
Peer comparison
Usan Pharmaceuticals Private Limited is compared with the 6 companies closest to it by revenue in the Pharma industry (Pharma Retail and Distribution, Pharmaceuticals), with the same principal business activity (wholesale trading), from the latest filed financials of each company.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Steranco Healthcare Private Limited | ₹29.92 Cr (FY 2025) | 121.0% | Mumbai, Maharashtra, India | |||
| Anekant Pharmaceuticals Private Limited | ₹29.83 Cr (FY 2021) | 54.0% | Delhi, India | |||
| Usan Pharmaceuticals Private Limitedthis company | ₹29.79 Cr (FY 2025) | -₹76.03 Lakh | -2.6% | -7.0% | Mumbai, Maharashtra, India | |
| Nemus Pharmaceuticals Private Limited | ₹29.76 Cr (FY 2025) | 21.0% | Kahalapur, Maharashtra, India | |||
| Vrnda Pharma Private Limited | ₹29.73 Cr (FY 2025) | 164.0% | Mumbai, Maharashtra, India | |||
| Cedric Pharmaceuticals Private Limited | ₹29.69 Cr (FY 2025) | 15.0% | Delhi, India | |||
| Infugen Pharma Private Limited | ₹29.66 Cr (FY 2025) | -21.0% | Sangli, Maharashtra, India |
To see the full peer comparison of Usan Pharmaceuticals Private Limited, buy the company report.
Auditor
Usan Pharmaceuticals Private Limited is audited by DEEPALI GORDE & CO for the financial year 2023.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| DEEPALI GORDE & CO | FY 2023 | 146948W |
Shareholding
The shareholding of Usan Pharmaceuticals Private Limited is on record for 5 financial years, the latest being FY 2023, split between promoters, domestic institutions, foreign institutions, public shareholders and others.
| Shareholder category | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 |
|---|---|---|---|---|---|
| Promoters | |||||
| Domestic institutional investors (DII) | |||||
| Foreign institutional investors (FII) | |||||
| Public | |||||
| Others |
To see the full shareholding pattern of Usan Pharmaceuticals Private Limited, buy the company report.
Charges & borrowings
| Date | Charge ID | Lender | Amount | Status | Modified or satisfied on |
|---|---|---|---|---|---|
| 26 Nov 1984 | 90184914 | Andhra Bank | ₹1.4 Lakh | Open | |
| 17 Apr 1984 | 90184853 | Usan Pharmaceuticale Pvt. | ₹3.15 Lakh | Open | |
| 28 Oct 1980 | 90184588 | State Bank of India | ₹25,000 | Open |
Total charge records: 3 View all charges
Legal cases
Usan Pharmaceuticals Private Limited has 7 court cases on record: 1 filed by Usan Pharmaceuticals, 6 filed against it. 2 cases are pending and 5 are disposed.
Cases by court
| Court | Cases | Against the company | Pending |
|---|---|---|---|
| High courts | 4 | 4 | 1 |
| District courts | 3 | 2 | 1 |
Cases on record (5 of 7)
| Court | Type of case | Party | Status |
|---|---|---|---|
| Bombay High Court | Court case (S) | Filed against the company by Hab Pharmaceuticals and Research Ltd. | Disposed |
| Bombay High Court | Interim or miscellaneous application | Filed against the company by Hab Pharmaceuticals and Research Limited | Disposed |
| High Court, MAHARASHTRA | Court case (COMIP) | Filed against the company by Syncom Formulations (I) Ltd. and 1 other | Pending |
| District court, Mumbai CMM Courts, Maharashtra | Court case (S W) | Filed against the company by Assistant Commissioner of Income Tax | Pending |
| High Court, MAHARASHTRA | Interim or miscellaneous application | Filed against the company by Syncom Formulations (I) Ltd. | Disposed |
To see the full case history of Usan Pharmaceuticals Private Limited, buy the company report.
Case records are compiled from court listings and may lag the court's own records. A case filed against a company is not a finding against it.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Usan Pharmaceuticals Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
Usan Pharmaceuticals has 1 GST registration: 1 active.
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 27AAACU0091N1Z4 | Maharashtra | Active | 01 Jul 2017 |
To see the full GST registrations and return filing status of Usan Pharmaceuticals Private Limited, buy the company report.
Recent activity
Usan Pharmaceuticals Private Limited has 6 board changes on record since 2001: 2 appointments and 4 cessations. The latest: Julie Vimal Jaswa ceased to be Additional Director on 30 Sep 2019.
Frequently asked questions
Usan Pharmaceuticals is an active private limited company based in Mumbai, Maharashtra, India. The company works in pharmaceutical retailers and distributors, within the pharma industry. It was incorporated on 13 August 1974 (52+ years old) and is registered under CIN U24239MH1974PTC017730.
Usan Pharmaceuticals has 2 current directors:
- Vimal Jaswa - Managing Director
- Julie Vimal Jaswa - Director
The latest financial statements of Usan Pharmaceuticals on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 30 September 2025. Year-wise statements from 2015 are in the company report.
The GSTIN of Usan Pharmaceuticals is 27AAACU0091N1Z4, registered in Maharashtra.
The CIN (Corporate Identification Number) of Usan Pharmaceuticals is U24239MH1974PTC017730. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Usan Pharmaceuticals has 7 court cases on record: 1 filed by the company and 6 filed against it. 2 are pending. Most are in the high courts.
Usan Pharmaceuticals was incorporated on 13 August 1974, making it 52+ years old. It is registered with the Registrar of Companies, Mumbai.
The peers of Usan Pharmaceuticals by revenue are Steranco Healthcare Private Limited, Anekant Pharmaceuticals Private Limited, Nemus Pharmaceuticals Private Limited, Vrnda Pharma Private Limited, Cedric Pharmaceuticals Private Limited and 1 more, all in the Pharma industry (Pharma Retail and Distribution, Pharmaceuticals), with the same principal business activity (wholesale trading).
Julie Vimal Jaswa ceased to be Additional Director on 30 Sep 2019. Julie Vimal Jaswa was appointed as Director on 15 Mar 2019. Premlata Pratap Jaswa ceased to be Director on 15 Mar 2019. Usan Pharmaceuticals has 6 board changes on record in total.
Usan Pharmaceuticals can be reached through the website usanpharma.com. Its registered office is in Mumbai, Maharashtra, India.
The registered office of Usan Pharmaceuticals is at 39 – B Syren Road Andhri East, Mumbai, Maharashtra, India – 400093.
Sample company reports
The same report you get when you buy one: financials, directors, ownership, deals, charges, legal cases, brands and filings, with the Excel workbook alongside.
